Mesenchymal stem cell-derived extracellular vesicles exert Th1-mediated anti-inflammatory effects via miR-146a/NF-κB pathway: comparison with dupilumab in a mouse model of atopic dermatitis

杜皮鲁玛 特应性皮炎 间充质干细胞 细胞外小泡 免疫学 医学 干细胞 癌症研究 细胞外 生物 细胞因子 单克隆抗体 体内 干细胞疗法 免疫系统 胞外囊泡 免疫疗法 抗体 干细胞因子
作者
Doil Park,Joo Ho Kim,Hyeock Yang,Yeeun Ji,Jaein Yoo,Jieun Kim,Oh Young Bang
出处
期刊:Stem Cell Research & Therapy [BioMed Central]
卷期号:16 (1): 496-496 被引量:12
标识
DOI:10.1186/s13287-025-04649-z
摘要

Abstract Background Atopic dermatitis (AD) is a chronic inflammatory skin disease primarily treated with corticosteroids and dupilumab, a monoclonal antibody targeting interleukin (IL)-4 and IL-13. Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) are promising alternatives owing to their anti-inflammatory properties. This study compared the therapeutic effects of dupilumab and MSC-EVs in a murine model of AD. We employed clinical, serological, and histological analyses to assess the efficacy of these treatments and investigated their mechanisms in vitro and in vivo. Methods We generated Wharton’s jelly MSC-EVs using a 3D microwell-based platform and evaluated their effects in an AD mouse model. AD was induced by repeated application of 2,4-dinitrochlorobenzene (DNCB) and sodium dodecyl sulfate (SDS). The mice were randomly divided into four groups: healthy (normal), placebo (DNCB + SDS), EV (6 × 108 particles once), and dupilumab (25 mg/kg biweekly) groups. Dupilumab and EVs were injected subcutaneously into the dorsal skin of the mice. Dermatitis scores, serum inflammatory markers, and histological analyses were performed to evaluate disease severity and changes at the tissue level. Additionally, tumor necrosis factor (TNF)-α-induced HaCaT cells were utilized for in vitro experiments to investigate the molecular mechanisms of MSC-EV therapy. Results EVs and dupilumab improved the clinical dermatitis score, reduced epidermal thickness, and promoted restoration of the skin barrier in mice with AD. Treatments decreased T helper (Th)2 and pro-inflammatory cytokines, but EVs, unlike dupilumab, effectively suppressed Th1 and Th22 cytokines. EVs suppress Th1 activation through the AKT/NF-κB pathway via microRNA-146a. Conclusions MSC-EVs offer a novel cell-free therapy for AD, demonstrating comparable or superior efficacy to dupilumab, with broader immunomodulatory effects and the advantage of a single-dose administration.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
医科大学菜鸡完成签到,获得积分10
刚刚
1秒前
酷波er的应助被ttttt采纳,获得10
1秒前
杨知意完成签到,获得积分10
1秒前
AZOEZ发布了新的文献求助10
1秒前
2秒前
2秒前
英吉利25发布了新的文献求助10
2秒前
3秒前
3秒前
3秒前
贝比东cry发布了新的文献求助10
4秒前
科研通AI6.3的应助被融融虫采纳,获得10
5秒前
lingling发布了新的文献求助30
5秒前
陈宛婷完成签到,获得积分10
5秒前
欣喜雁荷发布了新的文献求助10
5秒前
123完成签到,获得积分10
6秒前
6秒前
7秒前
7秒前
7秒前
7秒前
8秒前
8秒前
贝比东cry完成签到,获得积分20
9秒前
Akim的应助被drizzle采纳,获得10
10秒前
破坏王完成签到,获得积分10
11秒前
领导范儿的应助被wangyimin采纳,获得10
11秒前
Oliver发布了新的文献求助10
11秒前
迷人胜完成签到,获得积分10
11秒前
汉堡包的应助被义气语兰采纳,获得10
11秒前
WJlife完成签到,获得积分10
11秒前
一颗杨桃发布了新的文献求助10
11秒前
12秒前
xiaoyan发布了新的文献求助10
13秒前
zhangmingyang发布了新的文献求助10
13秒前
阿wo完成签到 ,获得积分10
14秒前
温暖砖头发布了新的文献求助10
14秒前
菜虫虫发布了新的文献求助10
15秒前
神勇的又槐完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175556
求助须知:如何正确求助?哪些是违规求助? 9567240
关于积分的说明 21791502
捐赠科研通 7770174
什么是DOI,文献DOI怎么找? 3431868
关于科研通互助平台的介绍 2556244
邀请新用户注册赠送积分活动 2477299